Skip to main content

Ira M. Jacobson, MD

  • Specialties: Hepatology, Gastroenterology
  • Language: English
  • Phone: 212-263-3095
Schedule an Appointment

About Me

I became fascinated with biology as a child, when my elementary school teacher showed me the teeming life in a drop of pond water through a microscope. My ambition to become a doctor arose from medicine’s ideal combination of science and helping others.

Much later, I decided to specialize in gastroenterology because of the diversity of conditions doctors manage in this field, and the scientific and technologic advances that characterized its dynamic growth early in my medical career. I was particularly fascinated with the liver because of the central role it plays in hundreds of the body’s vital processes.

I devote much of my clinical time caring for people who have liver disease, including viral hepatitis and other liver conditions. For patients who require liver transplantation, I work closely with our surgeons at the NYU Langone Transplant Institute. I am also actively involved in the broader specialty of gastroenterology and gastrointestinal endoscopy, including upper gastrointestinal endoscopy and colonoscopy.

As the director of hepatology at NYU Langone Health, I aim to expand and enhance the clinical, research, and educational programs in liver disease and mentor the exceptional group of hepatologists here. It’s an honor to work with such a wonderful hepatology team and to provide patient care alongside world-class experts in medicine, surgery, pathology, radiology, oncology, and other specialties.

The primary source of gratification in my professional life is patient care. I enjoy meeting my patients and their families and hearing about their lives, and I pride myself on spending as much time with my patients as they need. While I focus on their specific conditions, I do so in the broad context of their overall health.

I place an emphasis on accessibility in my practice—my patients can contact me at any time through secure electronic communication. I also emphasize clear communication during office visits. We live in an era of “evidence-based medicine,” but existing medical evidence must sometimes be combined with clinical experience and judgment for the best approach to care. To do this, I provide individualized care and focus on each person and how he or she is unique.

For more than 30 years, I have participated in hundreds of clinical trials on antiviral therapy for viral hepatitis, including hepatitis B and C, and I have also led a number of them. These studies have remarkably improved our ability to treat people with these conditions, including the capacity to cure nearly all patients who have hepatitis C. I have authored and coauthored more than 250 scientific papers, chapters, and reviews on these and other topics. I continue to be involved in studies on viral hepatitis, and am also involved in studies examining treatments for other liver diseases, such as fatty liver disease and primary biliary cholangitis.

I am a fellow of several major organizations, including the American College of Physicians, the American Gastroenterological Association, the American Association for the Study of Liver Diseases, and the American College of Gastroenterology, and a member of the European Association for the Study of the Liver. Recently, I was honored to be elected to a fellowship at the Royal College of Physicians in the United Kingdom. I am a past president of the New York Society for Gastrointestinal Endoscopy and the New York Gastroenterological Association.


Conditions and Treatments

Conditions
  • viral hepatitis
  • liver tumor
  • fatty liver
  • gallstone disease
  • liver diseases
  • autoimmune hepatitis
  • colon cancer screening
  • bile duct abnormalities
  • primary biliary cirrhosis
Treatments
  • endoscopy
  • colonoscopy

Credentials

Positions
  • Professor, Department of Medicine
  • Director, Hepatology
Board Certifications
  • American Board of Internal Medicine (Gastroenterology), 1985
  • American Board of Internal Medicine - Internal Medicine, 1982
Education and Training
  • Fellowship, Harvard Medical School, Gasteoenterology, 1984
  • Residency, University of California, San Francisco, School of Medicine, Internal Medicne, 1982
  • MD from Columbia University, 1979
Departments

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Insurance Plans Accepted

This provider accepts the following insurance plans.

  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna International
    • Aetna Medicare Managed Care
    • Aetna Meritain Health
    • Aetna Open Access Elect Choice (EPO)
    • Aetna Open Access HMO
    • Aetna POS
    • Aetna POS (American Express Employer)
    • Aetna PPO
    • Aetna Signature Administrators PPO
    • Aetna Student Health
    • Allied
    • Chesterfield Resources Inc
    • Christian Brothers Services
    • CoreSource
    • Healthscope
    • Nippon Life of America-Aetna
    • Nippon Life-Aetna
    • Starmark
    • WellNet
  • Blue Cross Blue Shield
    • BCBS Blue Access EPO
    • BCBS Blue Access GEPO
    • BCBS Blue Access HMO
    • BCBS EPO
    • BCBS EPO (BlackRock Employees)
    • BCBS EPO (NYU Winthrop Employees)
    • BCBS EPO - Empire EPO (NYU Langone Employees)
    • BCBS EPO - Empire EPO (Sunset Park/Family Health Center Employees)
    • BCBS EPO - Empire NYU Care (NYU Langone Employees)
    • BCBS EPO - Empire NYU Care (Sunset Park/Family Health Center Employees)
    • BCBS Federal Program
    • BCBS HMO
    • BCBS Indemnity
    • BCBS Mediblue Medicare HMO
    • BCBS Mediblue Medicare PPO
    • BCBS POS
    • BCBS PPO
    • BCBS PPO (BlackRock Employees)
    • BCBS PPO (NYU Winthrop Employees)
    • BCBS PPO - Empire PPO (Sunset Park/Family Health Center Employees)
    • BCBS Pathway
    • BCBS Pathway Enhanced
    • BCBS Pathway Enhanced
    • BCBS Pathway X Enhanced
    • BCBS Pathway X Enhanced
    • Local 32BJ SEIU
    • New York Hotel Trades
    • Unicare
  • Cigna
    • Apwu Health Plan
    • Cigna Great West PPO
    • Cigna HMO
    • Cigna Indemnity
    • Cigna Managed Care/POS
    • Cigna NALC
    • Cigna Open Access
    • Cigna Open Access PPO
    • Cigna PPO
    • Cigna Premier Plus
    • Consolidated Health Plans-NYU Student
    • Great West HMO
    • MVP-Cigna Network
  • GHI
    • GHI Medicare Supplement
  • NYSHIP - The Empire Plan
    • NYS Health Insurance Plan - The Empire Plan
  • Oxford
    • Oxford Health Plans Freedom
    • Oxford Health Plans Liberty
  • Railroad Medicare
    • Palmetto GBA Railroad Medicare
  • United Healthcare
    • AARP Medicare Complete
    • Oxford Health Plans Medicare Advantage
    • UMR
    • UMR WTC Health Program
    • United Healthcare AARP
    • United Healthcare Choice
    • United Healthcare Choice (AMEX employees)
    • United Healthcare Choice (Blackrock employees)
    • United Healthcare Choice (CBS employees)
    • United Healthcare Choice NSLIJ
    • United Healthcare EPO
    • United Healthcare EPO (NYU Langone Health Employees)
    • United Healthcare HMO
    • United Healthcare Indemnity
    • United Healthcare Indemnity (NYU Langone Health Employees)
    • United Healthcare JP Morgan
    • United Healthcare Medicare
    • United Healthcare Navigate
    • United Healthcare POS
    • United Healthcare PPO
    • United Healthcare Plus (NYU Langone Health Employees)
    • United Healthcare Student Resources
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Locations and Appointments

NYU Gastroenterology Associates

240 East 38th Street, 23rd Floor
New York, NY 10016

Phone

212-263-3095

Schedule Online

Research My Research

Interests

Hepatitis, Fatty liver disease, Priimary biliary choangitis, primary sclerosing cholangitis

Academic Contact

Academic office

530 First Avenue

HCC7H

New York, NY 10016

Phone

212-263-0474

Fax

212-263-0475

Clinical Trials and Research Studies

  • A Multi-center Open-label Long-term Extension Study of ABI-H0731 + Nucleos(t)ide as Finite Treatment for Chronic Hepatitis B Patients

    Learn More
  • A Multicenter Randomized Double-Blind Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis.

    Learn More
  • A Phase 2 Dose Ranging Randomized Double Blind Placebo-Controlled Study Evaluating the Safety Tolerability Pharmacokinetics and Efficacy of EDP-305 in Subjects with Primary Biliary Cholangitis (PBC) with or without an Inadequate Response to Ursodeoxycholic Acid (UDCA)

    Learn More
View All Research Studies (3)

Publications

Read All Publications (198)

Related News

We can help you find a doctor. Call 646-929-7800 or
browse our specialists.